Ironwood Pharmaceuticals (IRWD) Invested Capital (2016 - 2025)
Ironwood Pharmaceuticals (IRWD) has disclosed Invested Capital for 17 consecutive years, with -$62.2 million as the latest value for Q4 2025.
- Quarterly Invested Capital rose 79.37% to -$62.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$62.2 million through Dec 2025, up 79.37% year-over-year, with the annual reading at -$62.2 million for FY2025, 79.37% up from the prior year.
- Invested Capital hit -$62.2 million in Q4 2025 for Ironwood Pharmaceuticals, up from -$64.7 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $722.8 million in Q4 2021 to a low of -$334.1 million in Q1 2025.
- Historically, Invested Capital has averaged $160.9 million across 5 years, with a median of -$63.4 million in 2025.
- Biggest five-year swings in Invested Capital: surged 11667.84% in 2021 and later crashed 155.55% in 2025.
- Year by year, Invested Capital stood at $722.8 million in 2021, then dropped by 9.74% to $652.4 million in 2022, then tumbled by 122.49% to -$146.7 million in 2023, then crashed by 105.36% to -$301.3 million in 2024, then surged by 79.37% to -$62.2 million in 2025.
- Business Quant data shows Invested Capital for IRWD at -$62.2 million in Q4 2025, -$64.7 million in Q3 2025, and -$108.8 million in Q2 2025.